12:25:10 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



Helius Medical Technologies Inc (2)
Symbol HSM
Shares Issued 25,498,703
Close 2019-02-06 C$ 9.35
Market Cap C$ 238,412,873
Recent Sedar Documents

Helius Medical to release fiscal 2018 results March 14

2019-02-07 08:23 ET - News Release

Mr. Mike Piccinino reports

HELIUS MEDICAL TECHNOLOGIES TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS ON MARCH 14, 2019

Helius Medical Technologies Inc. will release its fourth quarter and fiscal year 2018 financial results after the market closes on Thursday, March 14.

Management will host a conference call at 4:30 p.m. ET on March 14 to discuss the results of the quarter and the year. Those who would like to participate may dial 866-393-4306 (734-385-2616 for international callers) and provide access code 8929969. A live webcast of the call will also be provided on the events section of the company's investor relations website.

For those unable to participate, a replay of the call will be available for two weeks at 855-859-2056 (404-537-3406 for international callers), access code 8929969. The webcast will be archived on the events section of the company's investor relations website.

About Helius Medical Technologies Inc.

Helius Medical Technologies is a neurotech company focused on neurological wellness. The company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. The company's first product in development is the Portable Neuromodulation Stimulator (PoNS).

© 2024 Canjex Publishing Ltd. All rights reserved.